NCT03862794View on ClinicalTrials.gov

CMO Letter to Reduce Unnecessary Antibiotic Prescribing and Broad Spectrum Prescribing Winter 2018-9

NACompletedINTERVENTIONAL
Enrollment

7,000

Participants

Timeline

Start Date

November 1, 2018

Primary Completion Date

April 30, 2019

Study Completion Date

May 30, 2019

Conditions
Prescribing, Off-Label
Interventions
BEHAVIORAL

new social norm feedback letter with bar chart

letter with the percentile prescribing the practice is on and a bar chart, comparing prescribing to the national average

BEHAVIORAL

standard social norm feedback letter

social norm feedback letter used as standard practice, without specific information about the prescribing percentile

Trial Locations (1)

SE1

Public Health England, London

All Listed Sponsors
lead

Public Health England

OTHER_GOV

NCT03862794 - CMO Letter to Reduce Unnecessary Antibiotic Prescribing and Broad Spectrum Prescribing Winter 2018-9 | Biotech Hunter | Biotech Hunter